Boltwood Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489K Buy
6,253
+2,070
+49% +$167K 0.11% 141
2026
Q1
$362K Buy
4,183
+1,768
+73% +$169K 0.09% 144
2025
Q4
$232K Buy
+2,415
New +$235K 0.06% 172

Other funds holding MDT

Boltwood Capital Management's MDT Position: Q2 2026 in Review

Boltwood Capital Management increased its Medtronic (MDT) stake by 49% in Q2 2026, buying an estimated $167K and bringing the position to 6,253 shares worth $489K. The position accounts for 0.11% of the portfolio, ranked #141.

Boltwood Capital Management first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. 535 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Boltwood Capital Management held 6,253 shares of Medtronic worth $489K as of Q2 2026.
  • Boltwood Capital Management bought 2,070 Medtronic shares in Q2 2026, an estimated $167K.
  • Medtronic made up 0.11% of Boltwood Capital Management's portfolio in Q2 2026, its #141 holding.
  • Boltwood Capital Management first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • 535 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Boltwood Capital Management's 13F filing for Q2 2026, filed 6 Jul 2026.